U.S. Transportation Stock News

NYSE:ACN
NYSE:ACNIT

Accenture (ACN) Stock Price Slide Sparks Fresh Questions On Long-Term Value

If you are wondering whether Accenture stock now offers value after a rough patch, you are not alone. This article will walk through what the current price might be implying. Accenture recently closed at US$128.98, with the share price up 3.3% over the last 7 days but down 31.1% over the last 30 days and down 50.4% year to date. This frames a sharp reset in expectations. Over the past year, investors have been reacting to company specific news and broader sector sentiment, which has seen...
NasdaqGS:ASTS
NasdaqGS:ASTSTelecom

AST SpaceMobile Stock Stands Out In 3 Telecom Picks For Global Connectivity

The new BT and Verizon joint venture, with $4b in annual revenue and an AI-ready global platform planned across 180 countries, puts fresh attention on how telecom stocks might respond to large scale corporate reshaping. For investors, this kind of deal can change cash flows, competition and capital priorities across the sector. This article looks at 3 stocks from our Global Telecommunications Sector screener that appear positively exposed to this news and may help you assess whether they...
NasdaqCM:MLTX
NasdaqCM:MLTXBiotechs

MoonLake Immunotherapeutics (MLTX) Is Down 10.2% After $200M Follow-On Offering To Fund Sonelokimab Push - Has The Bull Case Changed?

MoonLake Immunotherapeutics recently completed a US$200,000,000 follow-on equity offering, issuing 9,000,000 Class A ordinary shares at US$20 each and 1,000,000 pre-funded warrants at US$19.9999, shortly after releasing past Week 52 Phase 3 VELA data showing strong efficacy and a consistent safety profile for sonelokimab in hidradenitis suppurativa. The pairing of robust long-term clinical results in both adult and adolescent patients with fresh capital raises highlights how MoonLake is...
NYSE:INSP
NYSE:INSPMedical Equipment

Why Inspire Medical Systems (INSP) Is Up 10.6% After Russell Index Reclassification To Small Cap

In late June 2026, Inspire Medical Systems, Inc. (NYSE: INSP) was removed from the large- and mid-cap Russell 1000 and Russell Midcap indices and added to a range of smaller-cap and style benchmarks, including the Russell 2000, Russell 2000 Growth and Value, Russell 2500 Value, and several Russell 3000-based value indices. This reshuffling shifts Inspire into the small‑cap and value‑oriented segments of the Russell family, potentially changing which index-linked investors hold the stock and...
NasdaqGS:ALMS
NasdaqGS:ALMSPharmaceuticals

Alumis (ALMS) Is Up 7.3% After Russell Reclassifies It Into Growth Indices What’s Changed

In late June 2026, Alumis Inc. (NasdaqGS: ALMS) was removed from several Russell value and microcap indices while being added to multiple Russell growth benchmarks, including the Russell 2000 Growth, 2500 Growth, and 3000 Growth indices. This reshuffling signals a formal shift in how index providers classify Alumis, from value and microcap exposure toward inclusion in growth-focused small- and mid-cap benchmarks. We’ll now examine how Alumis’s reclassification into Russell growth benchmarks...
NYSE:NEE
NYSE:NEEElectric Utilities

NextEra Stock And The AI Power Demand Story Investors Should Know

The AI surge is not only transforming software and chips, it is also reshaping the power grid that keeps data centers running. Record US$200b in M&A across the US power and utility sector highlights how critical reliable electricity has become for AI workloads. For investors, this creates a fresh way to think about exposure to AI, through companies tied to power generation, transmission, and distribution. This article breaks down how the AI-driven need for electricity links to real businesses...
NYSE:JHG
NYSE:JHGCapital Markets

Janus Henderson Group (JHG) Looks About Right, Is The DCF Warning Hard To Ignore?

Janus Henderson Group Stock Performance Snapshot Janus Henderson Group (JHG) recently closed at $51.93, giving the asset manager a market value of about $8.0b. The stock’s return over the past year sits at 36.21%, with a 112.22% total return over 3 years. For investors tracking longer trends, Janus Henderson Group shows a 64.80% total return over 5 years and an 8.69% gain year to date. In the shorter term, the stock is roughly flat over the past week and month, and up about 1.09% over the...
NasdaqGS:ACLS
NasdaqGS:ACLSSemiconductor

Axcelis Technologies (ACLS) Is Down 5.8% After Russell Index Removal Reshapes Its Passive Ownership Profile

On 27 June 2026, Axcelis Technologies, Inc. was removed from multiple Russell value and small‑cap benchmarks, including the Russell 2000 and Russell 3000 Value indices, reflecting a shift in how the stock fits within these index methodologies. This cluster of index deletions can matter for investors because passive funds tracking these benchmarks may adjust their holdings, potentially influencing trading activity and liquidity around Axcelis shares. We’ll now examine how Axcelis’s removal...
NasdaqGS:OTEX
NasdaqGS:OTEXSoftware

Open Text (OTEX) Rebound Puts Its AI And Cloud Narrative Back In Focus

Recent share performance for Open Text stock With no single headline event driving trading, Open Text (NasdaqGS:OTEX) has drawn attention after the stock rose 3.4% over the past day and 10.4% over the past week. Those short term gains contrast with a weaker stretch, with the share price down 7.3% over the past month and slightly lower over the past 3 months, while the year to date return shows a decline of 30.4%. See our latest analysis for Open Text. The recent rebound in Open Text’s share...
NasdaqGS:SYRE
NasdaqGS:SYREBiotechs

Is Spyre Therapeutics (SYRE) Fully Valued After Russell Index Removal And A $500 Million Offering?

Spyre Therapeutics (SYRE) was recently removed from several Russell Value benchmarks, a change that can influence trading as index funds adjust holdings and investors reassess the stock’s role in portfolios. See our latest analysis for Spyre Therapeutics. Spyre Therapeutics’ recent removal from several Russell Value benchmarks and the filing of a US$500 million follow on equity offering come after a sharp run, with the 90 day share price return of 74.25% and year to date share price return of...
NYSE:CCO
NYSE:CCOMedia

Is Broad Russell Index Inclusion Altering The Investment Case For Clear Channel Outdoor Holdings (CCO)?

Clear Channel Outdoor Holdings, Inc. (NYSE: CCO) was recently added to multiple Russell indices, including the Russell 2000, 2500, 3000, 3000E and related small-cap and value benchmarks. This broad index inclusion increases the company’s visibility with institutional investors and index-tracking funds that use Russell benchmarks as portfolio guides. We’ll now examine how Clear Channel Outdoor’s broad Russell index inclusion may influence its existing investment narrative and risk-reward...
NYSE:PHIN
NYSE:PHINAuto Components

Is PHINIA (PHIN) Expensive As Russell Index Additions Put It On More Radars?

PHINIA’s Index Additions Put the Stock on More Investors’ Radar PHINIA (PHIN) has been added to several Russell growth and small cap indices, a shift that can draw more attention from index funds and rules based strategies that track these benchmarks. These inclusions follow a strong share price run, with PHINIA up about 9.8% over the past month and roughly 28.7% in the past 3 months. For investors, the key question is whether current pricing already reflects this higher visibility or if...
NasdaqGS:STX
NasdaqGS:STXTech

3 AI Infrastructure Stocks Investors May Want To Watch As Spending Risks Rise

Artificial intelligence is drawing huge sums of capital, and the Bank for International Settlements is warning that this wave of AI spending could turn painful if expectations run ahead of reality. With tech giants projected to commit over $1t to AI projects in 2025 and 2026, and corporate debt used to fund these build outs, investors are right to ask which stocks might be most exposed to this theme. This article looks at 3 stocks from our AI Hardware & Infrastructure Providers screener that...
NYSE:ESNT
NYSE:ESNTDiversified Financial

Does Essent Group's (ESNT) Rising Dividend Signal Deep Management Confidence or Strategic Caution?

In recent days, Essent Group has drawn attention for its 2.27% dividend yield, which is higher than both its industry and S&P 500 averages, and for having raised its dividend five times in the past five years. An interesting angle for investors is that this pattern of consistent dividend growth, combined with expectations for earnings expansion, is being interpreted as a signal of management’s confidence in Essent’s financial strength and capacity to sustain shareholder returns. Building on...
NYSE:SNDA
NYSE:SNDAHealthcare

Sonida Senior Living (SNDA) Is Up 8.5% After Broad Russell Index Removal Has The Bull Case Changed?

On 27 June 2026, Sonida Senior Living, Inc. was removed from multiple Russell equity indices, including the Russell 3000E, Russell 2000 Growth, Russell Microcap and several related growth and value benchmarks. This broad index removal can matter for investors because it often prompts mechanical selling by index-tracking funds, altering Sonida’s shareholder base and liquidity profile. We’ll now explore how Sonida’s broad removal from Russell indices may influence its existing investment...
NasdaqGS:LSTR
NasdaqGS:LSTRTransportation

Heathrow Expansion Could Shift These 3 Airline Industry Stocks

The Heathrow third runway debate has quickly turned into more than an infrastructure story; it is now a live risk and opportunity filter for airlines with meaningful exposure to the airport. With concerns over a £33b project, competing expansion plans, and open government signals on lower cost bids, the winners and losers may not be obvious at first glance. This article picks out 3 airline stocks from our screener that appear most directly exposed to the latest Heathrow news, and explains how...
NYSE:GHM
NYSE:GHMMachinery

Graham (GHM) Could Be 3% Undervalued Following Russell 2000 Index Additions

Index additions put Graham in focus for liquidity minded investors Graham (GHM) has been added to both the Russell 2000 Defensive Index and the Russell 2000 Growth-Defensive Index, an inclusion that typically brings higher visibility and potential liquidity for the stock. See our latest analysis for Graham. The index additions come after a period of strong momentum for Graham, with the share price up 61.22% over the past 90 days and a year-to-date share price return of 83.28%. The 3-year...
NasdaqGS:ROST
NasdaqGS:ROSTSpecialty Retail

Ross Stores Stock And 2 Affordable Fitness Retail Picks To Watch

Free and low cost sports programs are reshaping how people access tennis courts, football pitches and fitness sessions, and that ripple effect reaches listed companies built around affordable sports and fitness brands. As more consumers try grassroots and community options, pressure on higher priced offerings grows, while value focused products and services may see renewed attention. This article looks at three stocks exposed to that trend from the Affordable Sports and Fitness Brands...
NYSE:SHO
NYSE:SHOHotel and Resort REITs

Will Q2 2026 Results Timing and Momentum Rating Shift Sunstone Hotel Investors' (SHO) Narrative?

Sunstone Hotel Investors recently announced it will release its second-quarter 2026 results on August 6, 2026, before the market opens, followed by a same-day conference call and live webcast for investors. At the same time, the company has drawn attention with a top Zacks momentum-focused rating supported by positive earnings estimate revisions that have bolstered investor confidence. We’ll now examine how the strong Zacks momentum rating and earnings estimate revisions shape Sunstone Hotel...
NasdaqGS:GLUE
NasdaqGS:GLUEBiotechs

Does Monte Rosa Therapeutics' (GLUE) Shift Into Russell Growth Indices Recast Its Biotech Risk Profile?

Monte Rosa Therapeutics, Inc. (NasdaqGS: GLUE) was recently removed from several Russell Value benchmarks and added to multiple Russell Growth benchmarks, including the Russell 2000 Growth, 2500 Growth, 3000 Growth, 3000E Growth, Small Cap Comp Growth, and Microcap Growth indices. This broad shift from Value to Growth classifications across the Russell index family highlights a change in how index providers now categorize Monte Rosa’s profile within the small-cap biotech universe. We’ll now...
NYSE:HAE
NYSE:HAEMedical Equipment

Haemonetics’ Broad Russell Value Index Inclusion Might Change The Case For Investing In Haemonetics (HAE)

In late June 2026, Haemonetics Corporation (NYSE: HAE) was added to multiple Russell value-oriented and defensive benchmarks, including the Russell 2000 Value, Russell 2500 Value, Russell Small Cap Comp Value, Russell 3000 Value, and Russell 3000E Value indexes. This broad inclusion across several Russell value and defensive indexes can increase passive ownership, deepen liquidity, and reinforce Haemonetics’ positioning as a value-tilted medtech name in institutional portfolios. We’ll now...
NasdaqGS:NBIS
NasdaqGS:NBISSoftware

Nebius Stock And 2 AI Infrastructure Picks With Fast Growth And Insider Ownership

Fast growing stocks with high insider ownership sit at the crossroads of two powerful forces in today’s market, where AI investment, global rate decisions and shifting trade patterns are all front of mind. On one side, you have companies that analysts and management see as having strong growth potential. On the other, you have insiders who have chosen to keep significant skin in the game. This article focuses on that overlap and highlights 3 stocks from the Fast Growing Stocks With High...
NasdaqGS:SYNA
NasdaqGS:SYNASemiconductor

Microsoft Stock And 2 AI Stocks Worth Watching Now

Artificial intelligence is no longer just a tech buzzword; it is influencing everything from chip factories in Asia to cloud data centers in the US and Europe. With China’s industrial profits tied to AI investment, central banks still focused on inflation, and manufacturing and trade readings shaping sentiment, many investors are looking for focused ways to get exposure to the ChatGPT and AI trend without trawling through hundreds of stocks. This AI Stocks screener filters for companies...